[Correction of the symptoms of hereditary diseases by means of enzymatic imprinting].
D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases / Q000096:biosynthesis; D002790:Cholesterol 7-alpha-Hydroxylase / Q000096:biosynthesis; D004790:Enzyme Induction; D005690:Galactose / Q000627:therapeutic use*; D005693:Galactosemias / Q000188:drug therapy / Q000235:genetics*; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D051379:Mice; D008815:Mice, Inbred Strains; D011284:Pregnenolone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D005694:UTP-Hexose-1-Phosphate Uridylyltransferase / Q000096:biosynthesis
D011284:Pregnenolone; D001189:Aryl Hydrocarbon Hydroxylases; D002790:Cholesterol 7-alpha-Hydroxylase; D005694:UTP-Hexose-1-Phosphate Uridylyltransferase; D005690:Galactose
Korrektsiia simptomov nasledstvennykh zabolevaniĭ v éksperimente putem fermentativnogo imprintinga.